Co-Authors
This is a "connection" page, showing publications co-authored by Martine Valette and Maude Bouscambert-Duchamp.
Connection Strength
0.518
-
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020. Euro Surveill. 2021 01; 26(3).
Score: 0.230
-
Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19. Lancet Microbe. 2021 Sep; 2(9):e424.
Score: 0.060
-
Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial. Clin Microbiol Infect. 2021 Oct; 27(10):1494-1501.
Score: 0.059
-
Performance of Self-Collected Saliva Testing Compared with Nasopharyngeal Swab Testing for the Detection of SARS-CoV-2. Viruses. 2021 05 12; 13(5).
Score: 0.059
-
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect. 2020 07; 26(7):960-962.
Score: 0.055
-
Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
Score: 0.055